- Please choose product options by visiting QuickVue™ SARS Antigen Test.
![](https://360healthsvc.com/wp-content/uploads/2023/06/QuickVue-SARS-Antigen-Test-Product-Photo.jpg)
QuickVue™ SARS Antigen Test
In stock
The QuickVue SARS Antigen Test detects SARS-CoV-2 antigens directly from anterior nares swab specimens. The QuickVue SARS Antigen Test provides accurate and reliable results in 10 minutes, allowing for COVID-19 testing of symptomatic patients within the first five days of symptoms and asymptomatic patients when tested serially.
SKU QUD33937P
The QuickVue SARS Antigen Test detects SARS-CoV-2 antigens directly from anterior nares swab specimens. The QuickVue SARS Antigen Test provides accurate and reliable results in 10 minutes, allowing for COVID-19 testing of symptomatic patients within the first five days of symptoms and asymptomatic patients when tested serially.
SKU QUD33937P
Kit Contents
- Twenty-five (25) individually packaged test strips
- Twenty-five (25) reagent tubes
- Twenty-five (25) reagent solution
- Twenty-five (25) sterile nasal swabs
- One (1) COVID positive control swab
- One (1) negative control swab
- One (1) package insert
- One (1) procedure card
Performance Measures
- 96.6% Sensitivity
- 99.3% Specificity
Features
- Test for both symptomatic and asymptomatic COVID-19
- Detects all known COVID-19 Variants
- Visual results available in 10 minutes
- 24 months of shelf life
- Built-in procedural control features
- Two-color result format provides a simple interpretation for positive and negative results
- Room Temperature Storage
360 Health Services Acceptable Product Dating
We will ship product with expiration dating >= 30 days from order date.
Disclaimer
This product has not been FDA cleared or approved, but has been authorized by FDA under an EUA. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb- 3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
Due to FDA guidelines and supply chain demands all orders for this product are non-cancellable and non-returnable.
This Item is not for resale and you must provide a valid CLIA license number in order to purchase it.
Weight | N/A |
---|---|
UOM | Case/1 – 250 tests, Kit/1 – 25 tests |